Bone grafts are implantable materials that promote bone healing and bone formation. Over the last few years, the demand for bone grafting surgical procedures for replacing missing or defected bone with material from a patient’s own body, animal, or cadaver.
According to Allied Market Research, the global bone grafts and substitutes
market is expected
to reach $3.36 billion by 2028, growing at a CAGR of 4.3% from 2021 to 2028.
Rise in incidence of musculoskeletal conditions, technological advancements in
medical devices, and obesity and diabetes to boost risk of degenerative joint
diseases have boosted the growth of the market.
Recently, Royal Biologics, a leading company
that specializes in cellular & autologous technologies for advanced
healing, launched Advanced-Cell. The company’s fusion bone grafting
systems is launched for use in orthopedics and it combines several autologous
and bone grafting technologies in one convenient kit. Moreover, it offers the
use the option of optimal live cellular grafting option, which is integrated
with next-generation bone grafting technology to offer low-cost bundle option.
Bone grafting for dental reconstruction
Bone grafting has become vital tool in the dental
treatment as it helps repair a smile using dental implants. People who have
missing teeth or do not have ideal jaw bone structure can benefit from dental
implants to replace lost teeth or improve shape of the face. A successful
dental bone grafting process is almost undetectable. Thus, it has gained
importance over the years to strengthen the jaw bone.
In dental bone grafting processes, doctors take
a section of bone from another area of the patient’s body and use special bone
grafting material and graft it on to the jaw bone. Once the process the
completed, the bone graft take time to heal properly. Usually, it takes a few
months for grafted bones to create new, strong bone. However, in cases where
grafting is minor, the entire process takes a less time.
Bone grafts and substitutes are essential to
offer support, improve biologic repair, and fill voids. Neurosurgeons,
orthopaedics, periodontists, and craniofacial surgeons perform these processes.
While bone harvested from done site is standard for this procedures, there are
some limitations and issues by use of autograft such as chronic site pain or limited
quantity.
While there is heavy investment in the R&D
of bone grafting, there is no single ideal bone graft substitute and doctors
have the huge responsibility to develop biologic alternatives to improve
functional capabilities of bone graft substitute and if possible, reduce the
requirement of autograft.
In the future, more bone grafting substitutes
would enter the market that improve success rate of the surgery and help
patients in recovery. Moreover, companies would invest colossal amount of money
in R&D using latest technological innovations such as 3D printing and
automation to improve bone grafting surgical procedures.
0 Comments